Recursion Pharmaceuticals (RXRX) Net Margin (QoQ) (2020 - 2026)
Recursion Pharmaceuticals (RXRX) Net Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Recursion Pharmaceuticals | 1.59 Bn | 933.22 Mn | -6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -151,133.00 |
| Dec 31, 2025 | 283,108.00 |
| Sep 30, 2025 | -224,110.00 |
| Jun 30, 2025 | 47,903.00 |
| Mar 31, 2025 | 256,220.00 |
| Dec 31, 2024 | -356,800.00 |
| Sep 30, 2024 | 30,910.00 |
| Jun 30, 2024 | -1,415.00 |
| Mar 31, 2024 | 19,147.00 |
| Dec 31, 2023 | 2,922.00 |
| Sep 30, 2023 | -18,667.00 |
| Jun 30, 2023 | -15,805.00 |
| Mar 31, 2023 | -6,646.00 |
| Dec 31, 2022 | 366.00 |
| Sep 30, 2022 | 38,714.00 |
| Jun 30, 2022 | 18,725.00 |
| Mar 31, 2022 | 151,517.00 |
| Dec 31, 2021 | -72,528.00 |
| Sep 30, 2021 | -13,605.00 |
| Jun 30, 2021 | -50,404.00 |